Last year was a rough one for Tristel but it still remains a very good business. The potential opportunity in the US market looks priced in.
I see a lot of reasons for investors to like a business such as Tristel.
First and foremost, its business is very easy to understand. Most of its money is made selling disinfectants for medical devices used in hospitals under the Tristel brand. It also sells surface disinfectants under the Cache brand and has a very small business selling animal disinfectant products.